Analyze Diet
Veterinary immunology and immunopathology2013; 153(1-2); 128-133; doi: 10.1016/j.vetimm.2012.12.012

Hydrocortisone inhibits IFN-γ production in equine, ovine, and bovine PBMCs.

Abstract: Hydrocortisone is widely accepted as an anti-inflammatory agent and there are many products available containing hydrocortisone as an active ingredient. Surprisingly, there is little data available specifically on the immunological effects of hydrocortisone in large animals. Glucocorticoids are well-characterized for their ability to repress inflammation via a wide variety of mechanisms including suppression of cytokine production. In this study the effects of hydrocortisone on IFN-γ production by equine, bovine, and ovine PBMCs were assessed using flow cytometric or ELISpot analysis. Hydrocortisone suppressed mitogen-driven IFN-γ production by PBMCs from all three species of animals, confirming that this agent mediates anti-inflammatory effects in large animals. Although the results from this study were expected based on the precedence set in murine and human systems, it is important to understand the effects of administration of a compound or product in the species of interest as species-specific indications are not always available.
Publication Date: 2013-01-03 PubMed ID: 23351642DOI: 10.1016/j.vetimm.2012.12.012Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This study investigates the impact of hydrocortisone, a commonly used anti-inflammatory agent, on the production of IFN-γ by peripheral blood mononuclear cells (PBMCs) in large animals including horses, cows, and sheep. The research confirms that hydrocortisone effectively suppresses IFN-γ production, thus demonstrating its anti-inflammatory effects in these species.

Overview of Research

  • This research was spurred by an observed lack of data regarding the effects of hydrocortisone on the immune systems of large animals. Despite its wide use as an anti-inflammatory agent, its specific impacts are not well-documented in these species.
  • The focus of the study was on the cytokine IFN-γ, which is a critical immune system molecular messenger. Hydrocortisone’s effect on its production was analysed due to known connections between cytokine suppression and anti-inflammatory actions.

Methodology and Results

  • The researchers used flow cytometric or ELISpot analysis to measure the effects of hydrocortisone on IFN-γ production in PBMCs from horses, cows, and sheep.
  • The study discovered that hydrocortisone does indeed suppress mitogen-driven IFN-γ production by the PBMCs of these large animals, thereby verifying its anti-inflammatory effectiveness.

Implications and Significance

  • While this outcome was anticipated given previous results observed in murine and human systems, it’s crucial to establish the effects of particular compounds in specific species due to potential species-specific variations.
  • This study therefore contributes valuable data about the immunological effects of hydrocortisone in these large animals. This knowledge can be helpful in confirming safe and effective use of hydrocortisone-related treatments in veterinary medicine for these species.

Cite This Article

APA
McCandless EE, Rai SK, Mwangi D, Sly L, Franz LC. (2013). Hydrocortisone inhibits IFN-γ production in equine, ovine, and bovine PBMCs. Vet Immunol Immunopathol, 153(1-2), 128-133. https://doi.org/10.1016/j.vetimm.2012.12.012

Publication

ISSN: 1873-2534
NlmUniqueID: 8002006
Country: Netherlands
Language: English
Volume: 153
Issue: 1-2
Pages: 128-133
PII: S0165-2427(12)00449-7

Researcher Affiliations

McCandless, Erin E
  • Veterinary Medicine Research and Development, Pfizer Animal Health, Kalamazoo, MI, United States. erin.mccandless@pfizer.com
Rai, Sharath K
    Mwangi, Duncan
      Sly, Laurel
        Franz, Lilian C

          MeSH Terms

          • Animals
          • Anti-Inflammatory Agents / pharmacology
          • Cattle
          • Dose-Response Relationship, Drug
          • Flow Cytometry
          • Horses
          • Hydrocortisone / pharmacology
          • Interferon-gamma / biosynthesis
          • Leukocytes, Mononuclear / drug effects
          • Leukocytes, Mononuclear / immunology
          • Sheep
          • Species Specificity
          • T-Lymphocytes / drug effects
          • T-Lymphocytes / immunology

          Citations

          This article has been cited 1 times.
          1. Alam N, Xu W, Atenafu EG, Uhm J, Seftel M, Gupta V, Kuruvilla J, Lipton JH, Messner HA, Kim DD. Risk model incorporating donor IL6 and IFNG genotype and gastrointestinal GVHD can discriminate patients at high risk of steroid refractory acute GVHD. Bone Marrow Transplant 2015 May;50(5):734-42.
            doi: 10.1038/bmt.2015.19pubmed: 25774595google scholar: lookup